A number of other research analysts also recently issued reports on the company. Susquehanna Bancshares restated a hold rating and issued a $31.00 price objective on shares of Genesco in a research note on Tuesday, January 16th. SunTrust Banks upped their price objective on Genesco to $39.00 and gave the company a buy rating in a research note on Tuesday, January 9th. Zacks Investment Research downgraded Genesco from a hold rating to a sell rating in a research note on Tuesday, December 5th. Pivotal Research initiated coverage on Genesco in a research note on Thursday, January 25th. They issued a buy rating and a $44.00 price objective for the company. Finally, TheStreet downgraded Genesco from a c- rating to a d rating in a research note on Friday, December 1st. One investment analyst has rated the stock with a sell rating, seven have given a hold rating and five have issued a buy rating to the stock. The company currently has a consensus rating of Hold and a consensus target price of $37.90.
Genesco (NYSE GCO) opened at $38.15 on Wednesday. The stock has a market capitalization of $760.68, a price-to-earnings ratio of -6.03, a price-to-earnings-growth ratio of 1.24 and a beta of 1.32. The company has a debt-to-equity ratio of 0.29, a current ratio of 2.31 and a quick ratio of 0.47. Genesco has a 12 month low of $20.90 and a 12 month high of $63.50.
Genesco (NYSE:GCO) last announced its quarterly earnings data on Friday, December 1st. The company reported $1.02 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.12 by ($0.10). The business had revenue of $716.80 million during the quarter, compared to the consensus estimate of $706.58 million. Genesco had a negative net margin of 4.24% and a positive return on equity of 6.93%. The firm’s revenue for the quarter was up .8% compared to the same quarter last year. During the same quarter last year, the company earned $1.28 EPS. equities research analysts expect that Genesco will post 3.07 earnings per share for the current fiscal year.
Several hedge funds have recently bought and sold shares of GCO. Carillon Tower Advisers Inc. bought a new position in shares of Genesco during the 4th quarter worth $42,811,000. Legion Partners Asset Management LLC bought a new position in shares of Genesco during the 4th quarter worth $26,777,000. Royce & Associates LP purchased a new stake in Genesco during the 4th quarter worth about $11,130,000. Northern Trust Corp lifted its holdings in Genesco by 47.5% during the 2nd quarter. Northern Trust Corp now owns 586,814 shares of the company’s stock worth $19,893,000 after purchasing an additional 188,906 shares in the last quarter. Finally, JPMorgan Chase & Co. lifted its holdings in Genesco by 635.0% during the 3rd quarter. JPMorgan Chase & Co. now owns 190,388 shares of the company’s stock worth $5,026,000 after purchasing an additional 164,485 shares in the last quarter. Institutional investors own 98.38% of the company’s stock.
ILLEGAL ACTIVITY NOTICE: “Genesco (GCO) PT Set at $40.00 by Piper Jaffray Companies” was first published by The Ledger Gazette and is owned by of The Ledger Gazette. If you are viewing this news story on another publication, it was illegally stolen and reposted in violation of United States and international copyright & trademark legislation. The original version of this news story can be viewed at https://ledgergazette.com/2018/02/18/genesco-gco-pt-set-at-40-00-by-piper-jaffray-companies-2.html.
Genesco Company Profile
Genesco Inc is a retailer and wholesaler of footwear, apparel and accessories. The Company operates in five segments: Journeys Group, Schuh Group, Lids Sports Group, Johnston & Murphy Group and Licensed Brands. It relies on independent third-party manufacturers for production of its footwear products sold at wholesale.
Receive News & Ratings for Genesco Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genesco and related companies with MarketBeat.com's FREE daily email newsletter.